Thompson IM - Search Results

1

The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer.

Heath EI, Kattan MW, Powell IJ, Sakr W, Brand TC, Rybicki BA, Thompson IM, Aronson WJ, Terris MK, Kane CJ, Presti JC Jr, Amling CL, Freedland SJ. Heath EI, et al. Among authors: thompson im. Urology. 2008 Jan;71(1):151-5. doi: 10.1016/j.urology.2007.08.016. Urology. 2008. PMID: 18242385

2

Impact of previous local treatment for prostate cancer on subsequent metastatic disease.

Thompson IM, Tangen C, Basler J, Crawford ED. Thompson IM, et al. J Urol. 2002 Sep;168(3):1008-12. doi: 10.1016/S0022-5347(05)64562-4. J Urol. 2002. PMID: 12187210 Clinical Trial.

3

Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109.

Powell IJ, Tangen CM, Miller GJ, Lowe BA, Haas G, Carroll PR, Osswald MB, DeVERE WHITE R, Thompson IM Jr, Crawford ED. Powell IJ, et al. Among authors: thompson im jr. J Urol. 2002 Nov;168(5):2016-9. doi: 10.1016/S0022-5347(05)64285-1. J Urol. 2002. PMID: 12394698

4

Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of southwest oncology group study 8894.

Beer TM, Tangen CM, Bland LB, Thompson IM, Crawford ED. Beer TM, et al. Among authors: thompson im. J Urol. 2004 Dec;172(6 Pt 1):2213-7. doi: 10.1097/01.ju.0000147771.92104.83. J Urol. 2004. PMID: 15538234

5

Prognostic features in men who died of prostate cancer.

Thompson KE, Hernández J, Canby-Hagino ED, Troyer D, Thompson IM. Thompson KE, et al. Among authors: thompson im. J Urol. 2005 Aug;174(2):553-6; discussion 556. doi: 10.1097/01.ju.0000165184.72337.9d. J Urol. 2005. PMID: 16006890

6

Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial.

Etzioni RD, Howlader N, Shaw PA, Ankerst DP, Penson DF, Goodman PJ, Thompson IM. Etzioni RD, et al. Among authors: thompson im. J Urol. 2005 Sep;174(3):877-81. doi: 10.1097/01.ju.0000169255.64518.fb. J Urol. 2005. PMID: 16093979 Clinical Trial.

7

Diagnosing prostate cancer: through a glass, darkly.

Thompson IM, Lucia MS. Thompson IM, et al. J Urol. 2006 May;175(5):1598-9. doi: 10.1016/S0022-5347(06)00292-8. J Urol. 2006. PMID: 16600709 No abstract available.

8

Prostate cancer detection strategies.

Brand TC, Hernandez J, Canby-Hagino ED, Basler JW, Thompson IM. Brand TC, et al. Among authors: thompson im. Curr Urol Rep. 2006 May;7(3):181-5. doi: 10.1007/s11934-006-0019-8. Curr Urol Rep. 2006. PMID: 16630521 Review.

9

Chemoprevention of prostate cancer with finasteride.

Canby-Hagino ED, Brand TC, Hernandez J, Thompson IM. Canby-Hagino ED, et al. Among authors: thompson im. Expert Opin Pharmacother. 2006 May;7(7):899-905. doi: 10.1517/14656566.7.7.899. Expert Opin Pharmacother. 2006. PMID: 16634712 Review.

10

The prostate cancer prevention trial: design, biases and interpretation of study results.

Goodman PJ, Thompson IM Jr, Tangen CM, Crowley JJ, Ford LG, Coltman CA Jr. Goodman PJ, et al. Among authors: thompson im jr. J Urol. 2006 Jun;175(6):2234-42. doi: 10.1016/S0022-5347(06)00284-9. J Urol. 2006. PMID: 16697846

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

855 results

Search Page

Filters